Risedronate-induced intravascular haemolysis complicated by acute tubular necrosis.
Ozkurt
Zübeyde Nur
ZN
Güliter
Sefa
S
Keleş
Işik
I
Keleş
Hatice
H
D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D002118:Calcium / Q000008:administration & dosage; D012968:Etidronic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D007552:Isotonic Solutions / Q000008:administration & dosage; D007683:Kidney Tubular Necrosis, Acute / Q000139:chemically induced* / Q000150:complications / Q000473:pathology; D008875:Middle Aged; D000068296:Risedronic Acid; D012965:Sodium Chloride / Q000008:administration & dosage; D016896:Treatment Outcome
D050071:Bone Density Conservation Agents; D007552:Isotonic Solutions; D012965:Sodium Chloride; D005665:Furosemide; D000068296:Risedronic Acid; D012968:Etidronic Acid; D002118:Calcium